Reducing Non-Beneficial Treatments at the End of Life
Nicholas Graves, PhD, Deputy Director, Health Services and Systems Research at Duke-NUS and the SingHealth Duke-NUS Health Services Research Institute
to
Cancer aneuploidy: From evolutionary pressures to cellular vulnerabilities
Uri Ben-David, PhD, Tel Aviv University
to
“Unraveling the Genotype-Immunophenotype Chasm in Pancreatic Cancer”
Jashodeep Datta, MD
to
TBD
Paul Sternberg
to